Van der Ploeg Leonardus H.T. 4
4 · RHYTHM PHARMACEUTICALS, INC. · Filed Nov 6, 2018
Insider Transaction Report
Form 4
Van der Ploeg Leonardus H.T.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-11-02−10,000→ 30,894 totalExercise: $7.52Exp: 2025-12-30→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2018-11-02$7.52/sh+10,000$75,200→ 80,539 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-11-02−8,200→ 33,471 totalExercise: $4.59Exp: 2025-11-16→ Common Stock (8,200 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-11-02−10,000→ 55,430 totalExercise: $6.14Exp: 2027-04-04→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2018-11-02$4.59/sh+8,200$37,638→ 60,539 total - Sale
Common Stock
2018-11-02$30.09/sh−38,000$1,143,420→ 42,539 total - Exercise/Conversion
Common Stock
2018-11-02$6.14/sh+10,000$61,400→ 70,539 total
Footnotes (5)
- [F1]On November 2, 2018, Mr. Van der Ploeg sold 38,000 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]This transaction was executed in multiple trades at prices ranging from $30.00 to $30.31, inclusive; the price reported above reflects the weighted average sale price. Mr. Van der Ploeg hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The stock options vest and become exercisable in 48 successive, equal monthly installments measured from August 3, 2015.
- [F4]The stock options vest and become exercisable in 48 successive, equal monthly installments measured from January 6, 2017.
- [F5]The stock options vest and become exercisable in 48 successive, equal monthly installments measured from August 3, 2015.